BWIN trades 35.0% below Wall Street's consensus target of $27.33.
Last 12 months price action with 12-month analyst target path
The base valuation assumes BWIN achieves its forward estimates and maintains a stable P/E multiple of 10.1x. This scenario reflects the blended consensus of 9 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of June 23, 2026, The Baldwin Insurance Group, Inc. (BWIN) has a Wall Street consensus price target of $27.33, based on estimates from 9 covering analysts. With the stock currently trading at $23.52, this represents a potential upside of +35.0%. The company has a market capitalization of $1.76B.
Analyst price targets range from a low of $20.00 to a high of $35.00, representing a 55% spread in expectations. The median target of $27.00 aligns closely with the consensus average. The wide target spread reflects significant disagreement on fair value.
The current analyst consensus rating is Buy, with 5 analysts rating the stock as a Buy or Strong Buy,4 rating it Hold, and 0 rating it Sell or Strong Sell. The positive sentiment balance indicates moderate optimism about the stock prospects.
From a valuation perspective, BWIN trades at a trailing P/E of -47.0x and forward P/E of 10.1x. Analysts expect EPS to grow +529.3% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $8.49, with bear and bull scenarios of $5.35 and $11.18 respectively. Model confidence stands at 62/100, reflecting moderate uncertainty in projections.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
RYANRyan Specialty Holdings, Inc. | $4.3B | $33.26 | $38.38 | +9.8% | Hold | 17.1x | 19 |
AONAon plc | $67.2B | $313.63 | $395.40 | +24.4% | Buy | 16.6x | 38 |
MMCMarsh & McLennan Companies, Inc. | $85.3B | $174.06 | $210.40 | +20.9% | Hold | 16.9x | 26 |
WTWWillis Towers Watson Public Limited Company | $23.8B | $252.97 | $334.69 | +31.1% | Buy | 13.1x | 29 |
BROBrown & Brown, Inc. | $19.8B | $58.24 | $88.00 | +48.9% | Hold | 13.1x | 30 |
AJGArthur J. Gallagher & Co. | $53.8B | $209.08 | $260.82 | +21.8% | Buy | 16.1x | 29 |
ERIEErie Indemnity Company | $9.8B | $211.65 | — | — | — | 17.5x | — |
ACGLArch Capital Group Ltd. | $32.8B | $92.04 | $102.57 | +12.5% | Buy | 9.8x | 34 |
HIGThe Hartford Financial Services Group, Inc. | $35.6B | $129.50 | $151.56 | +18.2% | Buy | 10.0x | 42 |
TRVThe Travelers Companies, Inc. | $67.2B | $310.61 | $310.40 | +0.8% | Hold | 11.0x | 43 |
Quick answers to the most common questions about buying BWIN stock.
The consensus Wall Street price target for BWIN is $27.33, representing 35.0% upside from the current price of $23.52. With 9 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.
BWIN has a consensus rating of "Buy" based on 9 Wall Street analysts. The rating breakdown is predominantly bullish, with 5 Buy/Strong Buy ratings. The consensus 12-month price target of $27.33 implies 35.0% upside from current levels.
With a forward P/E of 10.0536x, BWIN trades at a relatively low valuation. The consensus target of $27.33 implies 35.0% appreciation, suggesting meaningful undervaluation.
The most bullish Wall Street analyst has a price target of $35 for BWIN, while the most conservative target is $20. The consensus of $27.33 represents the median expectation. Our quantitative valuation model projects a bull case target of $11 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
BWIN is moderately covered, with 9 analysts providing price targets and ratings. Of these, 1 have Strong Buy ratings, 4 have Buy ratings, 4 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month BWIN stock forecast based on 9 Wall Street analysts shows a consensus price target of $27.33, with estimates ranging from $20 (bear case) to $35 (bull case). The median consensus rating is "Buy". Our proprietary valuation model produces a base case fair value of $8, with bear/bull scenarios of $5/$11.
Our quantitative valuation model calculates BWIN's fair value at $8 (base case), with a bear case of $5 and bull case of $11. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 62/100.
BWIN trades at a forward P/E ratio of 10.1x based on next-twelve-months earnings estimates. The higher forward P/E suggests near-term earnings pressure. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Wall Street analysts are very optimistic on BWIN, with a "Buy" consensus rating and $27.33 price target (35.0% upside). 5 of 9 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
BWIN analyst price targets range from $20 to $35, a 55% wide spread indicating significant analyst disagreement. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $27.33 consensus represents the middle ground. Our model's $5-$11 range provides an independent fundamental perspective.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.